PRI's Focus on Health Care

View this email in your browser ([link removed])

Here’s What’s In Trump’s Healthcare Plan
Forbes | Sally C. Pipes
October 26, 2020

In the weeks since, the president’s team hasn’t exactly been forthcoming with details. But President Trump has hardly been inactive on health care during his term. In fact, his administration has taken a number of important but underappreciated steps to boost consumer choice and affordability in the healthcare marketplace.
Read more. . . ([link removed])

Dr. Henry Miller Talks COVID-19 Vaccine Rates on the John Batchelor Show
The John Batchelor Show | Henry Miller, M.S., M.D.
October 23, 2020

PRI’s Dr. Henry Miller joins the John Batchelor Show to discuss the lateset updates on a coronavirus vaccine. Dr. Miller talks about President Donald Trump’s treatment with remdisivir during his positive coronavirus diagnosis.
Listen here. . . ([link removed])

BidenCare would bring socialized medicine and end private health insurance
Fox News | Sally C. Pipes
October 26, 2020

The former vice president is trying to position himself as a moderate on health care — someone who will build on ObamaCare. But his plan, which he dubbed BidenCare for the first time during the debate, would absolutely nudge the U.S. toward government-run, single-payer health insurance.
Read more. . . ([link removed])

A Coronavirus Vaccine Is No Good If People Won’t Take It
American Council on Science and Health | Henry Miller M.S., M.D. and Andrew Fillat
October 20, 2020

There is widespread anticipation of vaccines to prevent COVID-19 infections so that Americans can get their lives back to some semblance of normal. More than 50 candidates, made with a variety of technology platforms, are now in clinical trials, 11 in large-scale, late-stage, safety/efficacy testing. During the large Phase 3 trials, which will involve tens of thousands of subjects, researchers will evaluate both the efficacy of the vaccine – that is, its ability to actually prevent infections — and to detect and quantitate less frequent side effects.
Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.